---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-003590"
form_type: "8-K"
ticker: "SPRB"
cik: "0001683553"
company_name: "SPRUCE BIOSCIENCES, INC."
filed_at: "2022-03-14T23:59:59+00:00"
generated_at: "2026-06-26T23:15:32.778166+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Spruce Biosciences enters ATM offering for up to $21M in common stock

## Summary
- Agreement with Jefferies LLC to sell up to $21M of common stock via at-the-market offerings.
- Shares sold at market prices on Nasdaq; Jefferies receives 3% commission on gross proceeds.
- Company not obligated to sell; offering may be suspended or terminated upon notice.
- Prospectus supplement filed under existing shelf registration effective Feb 11, 2022.

## SEC filing metadata
- accession: 0000950170-22-003590
- form_type: 8-K
- ticker: SPRB
- cik: 0001683553
- company_name: SPRUCE BIOSCIENCES, INC.
- filed_at: 2022-03-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1683553/000095017022003590/0000950170-22-003590-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1683553/000095017022003590/sprb-20220314.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-003590
- JSON: https://secwatch.observer/filing/0000950170-22-003590.json
- Plain text: https://secwatch.observer/filing/0000950170-22-003590.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.